Characteristics | Placebo (n = 23) | 100 mg/day 5-Loxin® (n = 24) | 250 mg/day 5-Loxin® (n = 23) |
---|---|---|---|
Sex (male/female; n) | 5/18 | 7/17 | 8/15 |
Age (years) | 52.43 ± 9.65 | 52.37 ± 8.37 | 53.22 ± 8.73 |
Body weight (kg) | 61.48 ± 10.69 | 61.08 ± 10.67 | 54.84 ± 10.19 |
Body mass index (kg/m2) | 26.05 ± 4.29 | 25.91 ± 4.94 | 22.64 ± 4.07 |
Visual analog score (mm) | 56.88 ± 12.04 | 57.05 ± 8.71 | 55.62 ± 9.26 |
Lequesne's Functional Index | 12.76 ± 2.6 | 12.1 ± 2.76 | 12.04 ± 3.03 |
WOMAC score | |||
Pain subscale | 38.04 ± 9.7 | 48.08 ± 14.05 | 37.17 ± 13.8 |
Stiffness subscale | 33.15 ± 13.3 | 31.8 ± 17.6 | 27.7 ± 16.8 |
Function subscale | 41.3 ± 9.6 | 41.5 ± 11.1 | 38.6 ± 11.1 |